Piedra, A., Piedra, A., Martínez-Recio, S., Hernández, A., Morán, T., Arriola, E., . . . Majem, M. First-line pembrolizumab in patients with advanced non-small cell lung cancer and high PD-L1 expression: Real-world data from a Spanish multicenter study. Frontiers Media S.A.
Chicago Style (17th ed.) CitationPiedra, Aida, et al. First-line Pembrolizumab in Patients with Advanced Non-small Cell Lung Cancer and High PD-L1 Expression: Real-world Data from a Spanish Multicenter Study. Frontiers Media S.A.
MLA (9th ed.) CitationPiedra, Aida, et al. First-line Pembrolizumab in Patients with Advanced Non-small Cell Lung Cancer and High PD-L1 Expression: Real-world Data from a Spanish Multicenter Study. Frontiers Media S.A.
Warning: These citations may not always be 100% accurate.